Is a naturally reduced antimüllerian hormone at a young age linked to an increased risk of cancer development?


Like Comment
Related Content

Volume 113, Issue 6, Pages 1161–1162


Human M. Fatemi, M.D., Ph.D., Barbara Lawrenz, M.D., Ph.D.


Reflections on "Increased chemotherapy-induced ovarian reserve loss in women with germline BRCA Mutations due to oocyte DNA repair deficiency" by Oktay et al.

Read the full text here. 

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.